Article
Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Jul 1998
Kwiatkowski D J, Harpole D H, Godleski J, Herndon J E, Shieh D B, Richards W, Blanco R, Xu H J, Strauss G M, Sugarbaker D J
Abstract excerpt
PURPOSE: To retrospectively construct a comprehensive multivariate model of cancer recurrence and to design a molecular pathologic substaging system in stage I non-small-cell lung cancer (NSCLC). METHODS: All patients with stage I NSCLC resected at Brigham and Women's Hospital (Boston, MA) betwee...
Topics
- Adult
- Aged
- Aged, 80 and over
- Carcinoma, Non-Small-Cell Lung
- DNA Primers
- Female
- Genes, ras
- Humans
- Karnofsky Performance Status
- Lung Neoplasms
- Lymphatic Metastasis
- Male
- Middle Aged
- Mutation